AGL and urinary bladder cancer: Lowering AGL enhanced tumour growth by increasing glycine synthesis through increased expression of serine hydroxymethyltransferase 2 (SHMT2), whilst depletion of the SHMT2 rescues the effects of tumour growth of bladder cancer cells without AGL [124].